Actionnariat et activité des initiés pour Stoke Therapeutics, Inc. (STOK): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $27.91 |
| Capitalisation | $1.8B |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $1.8M | $105.4M | $222.5M | $287.3M | $144.9M | $113.6M | $191.4M | $128.0M | $84.2M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | $74.9M | $116.0M | $10.0M | $88.9M | $200.4M |
| Créances | 0 | $196000 | $281000 | $6000 | $132000 | $588000 | $64000 | $700000 | $7.9M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $1.9M | $106.1M | $226.0M | $293.9M | $229.2M | $244.1M | $215.3M | $232.8M | $305.7M |
| Immobilisations Corporelles | $473000 | $1.2M | $2.5M | $3.8M | $9.1M | $11.4M | $12.4M | $8.3M | $6.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $2.4M | $107.5M | $228.8M | $297.9M | $238.9M | $256.1M | $228.3M | $271.6M | $418.4M |
| Dettes Fournisseurs | $141000 | $1.1M | $751000 | $1.5M | $2.4M | $766000 | $1.7M | $2.5M | $4.9M |
| Dette à Court Terme | $3.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $3.7M | $2.5M | $4.1M | $11.4M | $17.1M | $31.4M | $30.8M | $40.1M | $57.9M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $3.7M | $2.5M | $4.3M | $11.8M | $21.1M | $71.2M | $68.8M | $42.5M | $66.0M |
| Réserves | -$13.2M | -$25.7M | -$58.0M | -$110.3M | -$196.1M | -$297.1M | -$401.8M | -$490.8M | -$497.7M |
| Capitaux Propres | -$1.3M | $105.1M | $224.4M | $286.1M | $217.8M | $184.8M | $159.6M | $229.0M | $352.5M |
| Dette Totale | $3.0M | 0 | 0 | $1.1M | $5.0M | $2.4M | $2.1M | $4.8M | $3.0M |
| Dette Nette | $1.2M | -$105.4M | -$222.5M | -$286.2M | -$214.8M | -$227.2M | -$199.3M | -$212.1M | -$281.7M |
| Fonds de Roulement | -$1.8M | $103.7M | $221.9M | $282.5M | $212.1M | $212.7M | $184.5M | $192.7M | $247.8M |
Santé financière
| Dette / Capitaux propres | 0.01 |
| Ratio de liquidité | 7.69 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 16.42 |
Rentabilité
| Rentabilité des capitaux propres | -59.36% |
| Rentabilité du capital investi | -62.74% |
| Rentabilité des actifs | -52.77% |
| Marge brute | 84.67% |
| Marge opérationnelle | -809.69% |
| Marge nette | -753.60% |
Entreprises liées: ARDX · BCRX · NTLA · NVAX · PHVS · SYRE · UPB
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de STOK: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions